Strategies to mitigate non-specific binding include chemical modifications to increase specificity, such as altering the molecular structure of a compound. Additionally, using carrier proteins or nanoparticles can help target the delivery of a drug to specific tissues, reducing unintended interactions. Optimization of formulation and delivery routes also plays a role in minimizing non-specific binding.
